Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
14 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/caliway-announces-successful-eop2-meeting-with-the-fda-for-cbl-514-in-reduction-of-abdominal-subcutaneous-fat-302454923.html
17 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/caliway-selected-to-present-cbl-514-phase-2-study-results-for-dercums-disease-at-world-orphan-drug-congress-usa-2025-302431424.html
12 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/caliways-cbl-514-phase-2-study-cbl-0202-accepted-for-publication-in-the-aesthetic-surgery-journal-302399557.html
10 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/caliway-announces-cbl-514-second-phase-2b-study-results-cbl-0205-met-endpoints-302372120.html
11 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/caliway-announces-successful-study-results-from-cbl-0204-a-cbl-514-phase-2b-study-for-reducing-abdominal-subcutaneous-fat-met-all-primary-and-secondary-efficacy-endpoints-302329084.html
12 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/caliway-announced-ema-orphan-drug-designation-granted-to-cbl-514-for-dercums-disease-treatment-302302626.html
ABOUT THIS PAGE